08.07.2010
Sensimed raises CHF 10 million in series B financing
Sensimed SA recently received financing of CHF 10 million in a series B round co-led by Wellington Partners and Vinci Capital - Renaissance PME. The round was completed by current investor Blue Ocean Ventures, and by private and strategic investors.
The Swiss company located near Lausanne designs, develops, and commercializes integrated micro-systems for medical devices. One of their products, the SENSIMED Triggerfish®, is a revolutionary tool for continuous monitoring of fluctuations in intra-ocular pressure for the management of related diseases such as glaucoma.
Funds will be used to achieve approval in the US and in Asian countries, to commercialize the CE-marked device in selected geographies, to run post-marketing application trials and to fund ongoing operations.
Sensimed SA received the CTI Start-up Label in February 2008. The company has around 20 employees.
For further information go to: www.sensimed.com/